At AMR Action Fund, I work as a Venture Analyst in a dynamic role in advancing antimicrobial and antifungal innovations through investments. My role encompasses a spectrum of responsibilities, from deal sourcing and due diligence to negotiation and execution. My expertise in medicinal chemistry & antibiotic drug discovery and proficiency in data management underpin these efforts, ensuring informed decision-making in a complex landscape.Serving as a Board Observer at UTILITY therapeutics, our team celebrated the FDA approval of Pivya in April 2024. This milestone reflects our commitment in making an impact in the AMR field. With a foundation in scientific research and a flair for fostering strategic industry relationships, I am dedicated to advancing the development of essential antimicrobial therapies through cross-functional collaborations.
Listed skills include Analytical Chemistry, Teamwork, Organic Chemistry, Microsoft Office, and 18 others.